Mammalian target of rapamycin inhibition in hepatocellular carcinoma.
about
Neoplastic disease after liver transplantation: Focus on de novo neoplasmsOncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the LiteratureCeramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells.Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma.Mammalian target of rapamycin complex 1 (mTORC1) Is required for mouse spermatogonial differentiation in vivo.CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinomaEffect of rapamycin on endometriosis in mice.Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29).Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin.Preclinical study of CC223 as a potential anti-ovarian cancer agent.New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian CancerActivated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade.Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling.ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo.Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation.Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma
P2860
Q26798306-43A83274-BEC5-4B30-A180-884C4DEE9287Q28067445-C5CC03B9-F404-4331-AE19-90B1492645B8Q35912091-97F10997-34A8-4294-9147-B926631CD7A6Q36013408-1813ACBB-0FB7-4EB5-BA24-8F70AA157926Q36271477-81098794-CE83-42B3-8D03-D6AE2DD9FCE2Q36320156-50CD4C5F-03F7-4EA2-80D3-9FEB5391075DQ36411622-09E7C362-0BF2-4697-9C2E-83AB66BCC94EQ37002497-298E7A99-0CD4-449F-A409-53C1DAD16912Q38521775-0530DFD7-5403-43DF-9FD5-A741BE96EE61Q38893853-660C2657-C527-4F3B-90A8-C1ADCAB78B93Q39134670-22D4A86B-5CB7-44A0-BD0E-3F589116B772Q39546506-57083EA8-4973-46B9-8ACB-E23E118F6AF6Q39991768-486C8675-0807-443B-B560-732BC6C1227EQ40970978-9B234621-0AE6-4D40-A2E9-8127D6696CEDQ41709197-4D5B78E7-C4E4-4BEC-9F35-1E9CBABEB662Q42144129-F13440C2-F371-4493-B437-EAF12616846FQ42468960-F84D34EA-4E39-4753-8F8F-4EC4E3528A8BQ45175810-F311F20A-E050-4F0D-A8A1-AF67F68D430EQ47103348-F057D657-87BF-497A-BADC-F04E5D771721Q48597130-A3C1DD31-8010-4EEF-ABE0-63E877579B79Q58699656-A21D7A16-715C-443A-9E98-47827665C9DD
P2860
Mammalian target of rapamycin inhibition in hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Mammalian target of rapamycin inhibition in hepatocellular carcinoma.
@en
type
label
Mammalian target of rapamycin inhibition in hepatocellular carcinoma.
@en
prefLabel
Mammalian target of rapamycin inhibition in hepatocellular carcinoma.
@en
P2860
P356
P1476
Mammalian target of rapamycin inhibition in hepatocellular carcinoma.
@en
P2093
Jennifer Wu
René E Ashworth
P2860
P304
P356
10.4254/WJH.V6.I11.776
P577
2014-11-01T00:00:00Z